Charlotte Kloft
Professor
Department of Pharmacy
Federal Institute for Risk Assessment
Germany
Biography
since 2011 University professor and head of the Department of Clinical Pharmacy & Biochemistry at the Institute for Pharmacy of the Freie Universität Berlin 2005-2011 University professor and head of the Department of Clinical Pharmacy at the Institute of Pharmacy at the Martin-Luther-University Halle-Wittenberg 1999-2005 Scientific assistant / assistant professor at the Institute of Pharmacy, Freie Universität Berlin 1997-1999 Ph.D., Drug Metabolism / Pharmacokinetics, Clinical Pharmacokinetics, Hoechst Marion Roussel (now Sanofi), Frankfurt / Main 1993-1997 Research assistant at the Institute of Pharmacy, Freie Universität Berlin Academic education, university and state degrees / qualifications Since 2012 Permission to work with pathogens within the scope of § 44 ff of the Infection Protection Act (IfSG) Certified laboratories: Biosafety level 2 according to the EU Directive (C ouncil Directive 90/679 / EEC of 26 November 1990 on the protection of workers Agents at work, OJ No. L 374, p.1 ) 2003 Habilitation and granting of professorial competence in the field of clinical pharmacy, Freie Universität Berlin Title: Rational dosing strategies based on pharmacokinetics / pharmacodynamics models in tumor therapy; Appointment as private tutor 1997 Doctorate to Dr. rer. nat. (Summa cum laude) at the Department of Pharmacy, Freie Universität Berlin, headed by Prof. Dr. U. Jaehde and Prof. Dr. Dr. Dr. hc W. Schunack Title: Clinical pharmacokinetic and pharmacodynamic studies for the dosing optimization of platinum complexes 1992 Approbation as a pharmacist 1991-1992 Practical year: SANDOZ (today Novartis), Basel, public pharmacy 1987-1991 Study of Pharmacy at Johannes Gutenberg University, Mainz.
Research Interest
Pharmacokinetics, Drug Metabolism.
Publications
-
Deputy Managing Director of the Institute for Pharmacy of the Freie Universität Berlin and a member of the Institute Council
-
"Academic Center of Excellence" or successor programs of Pharsight (today: Certara), USA
-
Project Leader (PI) and member of the Steering Committee in the Research Group "ABIMMUNE" of the Joint Programming Initiative on Antimicrobial Resistance (BMBF) 031L0097)